FibroBiologics Inc’s recent filing unveils that its Chief Scientific Officer Khoja Hamid acquired Company’s shares for reported $16800.0 on May 27 ’25. In the deal valued at $0.84 per share,20,000 shares were bought. As a result of this transaction, Khoja Hamid now holds 31,250 shares worth roughly $23437.5.
Then, O’HEERON PETE bought 8,500 shares, generating $16,269 in total proceeds. Upon buying the shares at $1.91, the Chief Executive Officer now owns 6,056,647 shares.
Before that, Khoja Hamid bought 10,000 shares. FibroBiologics Inc shares valued at $19,000 were divested by the Chief Scientific Officer at a price of $1.90 per share. As a result of the transaction, Khoja Hamid now holds 11,250 shares, worth roughly $8437.5.
Rodman & Renshaw initiated its FibroBiologics Inc [FBLG] rating to a Buy in a research note published on December 12, 2024; the price target was $12. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Maxim Group began covering FBLG with “Buy” recommendation on September 24, 2024.
Price Performance Review of FBLG
On Tuesday, FibroBiologics Inc [NASDAQ:FBLG] saw its stock fall -5.48% to $0.75. Over the last five days, the stock has lost -19.52%. FibroBiologics Inc shares have fallen nearly -62.33% since the year began. Nevertheless, the stocks have fallen -89.51% over the past one year. While a 52-week high of $7.57 was reached on 01/07/25, a 52-week low of $0.70 was recorded on 06/02/25.
Levels Of Support And Resistance For FBLG Stock
The 24-hour chart illustrates a support level at 0.7341, which if violated will result in even more drops to 0.7150. On the upside, there is a resistance level at 0.7912. A further resistance level may holdings at 0.8292.
